2 insiders reported 12 Form 4 transactions for Black Diamond Therapeutics, Inc. (BDTX) over the past 18 months (most recent 2026-09-21). Recent activity: Behbahani Ali (Director) Buy 7,707 shares, Raman Prakash (Director) Buy 6,801 shares, Raman Prakash (Director) Buy 7,907 shares, Behbahani Ali (Director) Buy 8,961 shares, Behbahani Ali (Director) Buy 6,919 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-21 | Behbahani Ali | Director | Buy | 7,707 | $14,875 |
| 2026-09-21 | Raman Prakash | Director | Buy | 6,801 | $13,126 |
| 2026-06-22 | Raman Prakash | Director | Buy | 7,907 | $13,126 |
| 2026-06-22 | Behbahani Ali | Director | Buy | 8,961 | $14,875 |
| 2026-03-20 | Behbahani Ali | Director | Buy | 6,919 | $14,876 |
| 2026-03-20 | Raman Prakash | Director | Buy | 6,105 | $13,126 |
| 2025-12-15 | Behbahani Ali | Director | Buy | 5,208 | $14,374 |
| 2025-12-15 | Raman Prakash | Director | Buy | 4,665 | $12,875 |
| 2025-09-22 | Behbahani Ali | Director | Buy | 4,291 | $14,375 |
| 2025-09-22 | Raman Prakash | Director | Buy | 3,843 | $12,874 |
| 2025-06-20 | Raman Prakash | Director | Buy | 5,526 | $12,876 |
| 2025-06-20 | Behbahani Ali | Director | Buy | 6,170 | $14,376 |
来源：SEC Form 4 申报文件 · 截至 2026-09-21